Products

Primary tabs

Export products to Excel

Displaying 61 - 75 of 109
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Target ID/Validation
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Target ID/Validation
Alternative Name: Nestorone (NES) + Estradiol (E2) Vaginal Ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Alternative Name: Nestorone + Testosterone Gel
Development Status: Active Development
Target: Male
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Nestorone (NES) + Estradiol (E2) Transdermal Gel
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Lavax Vaginal Suppository
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal, Other
Project Stage: Target ID/Validation
Partner: Lavax
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Alternative Name: Nomegestrol acetate (NOMAC) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Partner: Merck
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Partner: Actavis
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier, Vaginal Ring
Project Stage: Phase II
Alternative Name: Phosphodiesterase (PDE) 3, 5, 9 inhibitors, PDE3A
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Target ID/Validation
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase III
Export to Excel